Featured Research

from universities, journals, and other organizations

Adding Taxotere To Chemotherapy Regimen Improves Survival In Early Breast Cancer, Study Suggests

Date:
September 16, 2008
Source:
European Society for Medical Oncology (ESMO)
Summary:
For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.

For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.

This advantage comes at the cost of an increased, but manageable, toxicity, Italian researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

Dr. Francesco Cognetti from Istituto Oncologico Regina Elena and colleagues treated 998 patients with node-positive early stage breast cancer with one of two regimens: 486 received four months of treatment with epirubicin, followed by four cycles of treatment with CMF. The remainder received an additional docetaxel treatment between the two chemotherapy stages.

At the congress, Dr. Cognetti reports results from a median follow-up of 62 months, showing a disease-free survival rate of 74% in the docetaxel arm, compared to 68% among women treated with the other regimen.

“At a median follow-up of five years, the overall survival of patients receiving the addition of docetaxel to the standard regimen of epirubicin followed by CMF significantly improved compared to patients randomized in the control arm,” he said. “Moreover, the time of disease recurrence results significantly longer in patients enrolled in the experimental arm.”

“The trial demonstrates that the introduction of four cycles of docetaxel into a sequential epirubicin-CMF regimen reduces the risk of recurrence and death in node-positive breast cancer patients.”


Story Source:

The above story is based on materials provided by European Society for Medical Oncology (ESMO). Note: Materials may be edited for content and length.


Cite This Page:

European Society for Medical Oncology (ESMO). "Adding Taxotere To Chemotherapy Regimen Improves Survival In Early Breast Cancer, Study Suggests." ScienceDaily. ScienceDaily, 16 September 2008. <www.sciencedaily.com/releases/2008/09/080915083801.htm>.
European Society for Medical Oncology (ESMO). (2008, September 16). Adding Taxotere To Chemotherapy Regimen Improves Survival In Early Breast Cancer, Study Suggests. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2008/09/080915083801.htm
European Society for Medical Oncology (ESMO). "Adding Taxotere To Chemotherapy Regimen Improves Survival In Early Breast Cancer, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2008/09/080915083801.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins